Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sirica, A. E.
Right arrow Articles by Guzelian, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirica, A. E.
Right arrow Articles by Guzelian, P. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

Evaluation of chlordecone in a two-stage model of hepatocarcinogenesis: a significant sex difference in the hepatocellular carcinoma incidence

Alphonse E. Sirica , Connie S. Wilkerson , Lauri L. Wu , Robert Fitzgerald 1, Robert V. Blanke  and Philip S. Guzelian 2

1Department of Pharmacology and Toxicology Richmond, VA 23298, USA
2Division of Clinical Toxicology and Environmental Medicine, Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University Richmond, VA 23298, USA
Department of Pathology Richmond, VA 23298, USA

Chlordecone (Kepone) has been extensively studied for its toxicity in male production workers who were exposed to large quantities of this organochlorine pesticide. Concern that these workers might be at an increased risk of developing liver cancer prompted us to test chlordecone in a two-stage rat model of hepatocarcinogenesis. Chlordecone acted largely as a liver tumor promoter rather than as a complete hepatic carcinogen in both male and female Sprague—Dawley rats. Dose—response experiments showed that the hepatocarcinogenic effects of long-term chlordecone administration became undetectable at concentrations in non-initiated rat liver in the same range as those measured in human biopsies taken from exposed workers who exhibited no liver effects. Although the toxicity of chlordecone in women has never been studied, we found a dramatic sex difference in the incidence of malignant liver tumors caused by chlordecone promotion in rats. Frank hepatocellular carcinomas were observed in up to 63% of female rats whose livers were previously ‘initiated’ with a subcarcinogenic dose of diethylnitrosamine given 24 h after partial hepatectomy, and then ‘promoted’ by 27 weeks of chlordecone administration. In contrast, none of comparably treated males had malignant liver tumors, even after 44 weeks of ‘promotion’ with chlordecone. Females in the diethylnitrosamine-initiated/chlordecone-promotion groups also contained {gamma}-glutamyltranspeptidase-positive ‘preneoplastic’ hepatocellular foci that were more abundant and larger than those observed in comparably-treated males. Moreover, because similar levels of chlordecone were measured in the livers of both sexes at the end of the experimental period, the development of hepatocellular carcinomas in the diethylnitrosamine-initiated female rats appeared to be due to their increased sensitivity to the promotion treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol Ind HealthHome page
O. Faroon, S. Kueberuwa, L. Smith, and C. Derosa
Atsdr Evaluation of Health Effects of Chemicals: II. Mirex and Chlordecone: Health Effects, Toxicokinetics, Human Exposure, and Environmental Fate
Toxicology and Industrial Health, November 1, 1995; 11(6): 1 - 195.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.